# An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

> **NCT00146523** · PHASE3 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 247 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00146523
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2006-07
- **Final completion:** 2006-07
- **Target enrollment:** 247 (ACTUAL)
- **Last updated:** 2012-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00146523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00146523, "An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT00146523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*